
--- Page 1 ---
1cs-0-3 (w/ ptpi l/eny) Sits . Breest nos c50.9 3/1 page 1 / 2 Department of Cancer Pathology . copy No. Date: Examination: Histopathological examination Internal invoice No. Cost of diagnostic procedure Examination No. Age: Gender: . Material: Multiple organ resection - left breast. Unit in charge Physician in charge: Material collected on: Material received or Expected time of examination: up to 8 working days Clinical diagnosis: Cancer of the left breast.  Examination performed on Results of immunohistochemical examination: Estrogen receptors found in over 75% of neoplastic cell nuclei.. Progesterone receptors found in over 75% of neoplastic cell nuclei.. HER2 protein stained with HercepTestTM by Score = 2+, verification by the FIsH method recommended.. Compliance validated by: Examination performed on: Macroscopic description: Left breast sized 26 x 20 x 5.5 cm removed along with axillary tissues sized 10 x 8 x 2.5 cm and a 25 x 14 cm skin. flap. Tumour sized 2.6 x 2 x 1.8 cm found in the outer lower quadrant, 5.3 cm from the lower boundary, 1.2 cm  from the base and 1.4 cm from the skin. Microscopic descriotion: Carcinoma ductale partim papillare - NHG1 (2 + 2 +3/22 mitoses/ 10 HPF, visual area diameter: 0.55 m).. Glandular tissue showing lesions of the type fibrosa et cystica, hyperplasia ductalis simplex Invasive lesions reaching the base. Axillary lymph nodes: Lymphonodulitis chronica et lymphonodorum No xV. Compliance validated by: UUID:72AF26A2-FAD0-42FD-A63C-6E8E2597B84E TCGA-D8-A1JT-01A-PR Redacted 24/

--- Page 2 ---
page 2 / 2 Examination: Histopathological examination (. Examination No. Gender Patient: xXx Examination performed on: Results of immunohistochemical examination: HER2 DNA Probe Kit  RESULT OF HER2/neu GENE AMPLIFICATION with the FISH method by FINAL RESULT: HER-2 gene AMPLIFICATION NOT FOUND. Histooathological diagnosis: I. Fibrocystic Mixed ductal and papillary invasive carcinoma of the left breast. Usual ductal hyperplasia ( changes. Lymph nodes negative for cancer.. Compliance validated by: